NEFL and myeloid sarcoma: Decreasing NfL levels in pediatric and adult MS patients have been consistently shown following disease-modifying therapy (Disanto et al., 2017; Sejbaek et al., 2019; Hyun et al., 2020; Reinert et al., 2020).